Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

roche_close

Roche’s Tecentriq improves OS in first-line lung cancer

March 26, 2018 Research and Development, Sales and Marketing Roche, biotech, drugs, lung cancer, pharma, pharmaceutical, tecentriq

Roche has revealed further data from its Phase 3, IMpower150 study, which showed that a combination of Tecentriq and Avastin, …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma

As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …
News
shutterstock_159488225

Promising drug for hormone therapy-resistant breast cancer enters human trials

March 22, 2018 Research and Development TTC-352, breast cancer, chicago, pharma

A team of researchers at Chicago’s University of Illinois (UIC) have revealed that their promising drug which could prove an …
News
architect_of_the_capitol_2

US “right to try” legislation passes after initial defeat

March 22, 2018 Medical Communications, Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma

The controversial and much-discussed “right to try” bill has been passed in the US House of Representatives, quickly rebounding after …
News
handshake

Regeneron-Alnylam team up to treat NASH

March 22, 2018 Research and Development, Sales and Marketing Alnylam, Regeneron, biotech, drugs, nash, pharma, pharmaceutical

Coming on the back of a Regeneron research piece published in the New England Journal of Medicine, the company announced …
News
brexit_flag_0

Independent committee report seeks Brexit healthcare clarity

March 21, 2018 Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical

An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …
News

NICE turns down Dompe’s eye drops for rare eye condition over price concerns

March 21, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Dompe, NICE, cenegermin, neurotrophic keratitis, pharma, rare disease

NICE has announced that it has recommended against the use of Dompe’s recombinant human nerve growth factor eye drop therapy …
News
takeda_global_hq

Takeda completes construction of new global headquarters in Tokyo

March 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, pharma, tokyo

Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital …
News
dominic_caruso

J&J’s longest-standing CFO finally steps down

March 21, 2018 Medical Communications, Research and Development J&J, JJ, Johnson & Johnson, biotech, cfo, drugs, pharma, pharmaceutical

Johnson & Johnson have revealed that its Chief Financial Officer and Executive Vice President, Dominic J. Caruso, will retire from …
News
celgene_1_02

Celgene bucks trend to strengthen neuroscience pipeline

March 21, 2018 Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical

Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …
News
shutterstock_38078521

Heron soars after its painkiller agent reduces pain and opioid use post-surgery at Phase 3

March 20, 2018 Manufacturing and Production, Research and Development heron therapeutics, opioid crisis, opioid epidemic, opioids, painkiller, pharma

Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary …
News
regeneron

Regeneron’s Eylea smashes Phase 3 trial goal in diabetic retinopathy

March 20, 2018 Manufacturing and Production, Research and Development Eylea, Regeneron, diabetes, pharma

Regeneron has confirmed that its vascular endothelial growth factor (VEGF) inhibitor injection Eylea (aflibercept) met its primary endpoint in a …
News
rocheroof

Roche’s immunotherapy improves PFS but unclear long-term benefit in lung cancer

March 20, 2018 Manufacturing and Production, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Roche’ Tecentriq needs a big result in the immunotherapy space – it initially burst onto the scene as a third-to-market …
News
john_mchutchison

New Chief Science and Medical Officers for Gilead

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …
Appointment
sperium-2505952_960_720

Male contraceptive pill hits safety goals

March 19, 2018 Research and Development, Sales and Marketing biotech, drugs, male contraceptive, pharma, pharmaceutical

A male contraceptive pill may be edging closer to the market, after a new formulation was shown to be safe …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026